GZW-12408-99363
4 vaccinations
2 coded responses
39 check-ins
1 free-text entry
0 call cases
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 921 / CA
- Registered
- 2021-03-22
- Relationship
- Self
- Race
- Asian
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-21
Dose 1 — Pfizer-BioNTech
-
2021-03-22
Registered in v-safe
-
2021-03-22
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain · Joint pains, Muscle or body aches, Fatigue or tirednessAdult check-in
- 2021-03-23
- 2021-03-24
- 2021-03-25
- 2021-03-26
- 2021-03-27
- 2021-03-28
- 2021-04-04
-
2021-04-11
Dose 2 — Pfizer-BioNTech
- 2021-04-11
-
2021-04-12
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activitiesAdult check-in
- 2021-04-13
- 2021-04-14
- 2021-04-15
- 2021-04-16
- 2021-04-17
- 2021-04-19
- 2021-04-25
- 2021-05-02
- 2021-05-09
- 2021-05-16
- 2021-05-23
- 2021-07-11
-
2021-08-20
Dose 3 — Pfizer-BioNTech
-
2021-10-10
Survey response — 6 months, dose 2MedDRA: Headache, Laboratory test abnormal, Medical counselling, Mobility decreased, Pain — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Received third dose of vaccine in August per PCP due to low antigen numbers in blood work. I was sick in bed for two days with body aches and headaches. Did not experience that severe reaction to first two doses.MedDRA releases: 2024-11 · check-in free text available
- 2021-11-19
- 2022-02-19
- 2022-08-20
-
2022-09-22
Dose 4 — Pfizer-BioNTech
-
2022-09-23
Health check-in — days 1–6 daily, dose 4Feeling: Poor · Site: Pain · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to work or attend school, Be unable to do your normal daily activitiesAdult check-in
-
2022-09-24
Health check-in — days 1–6 daily, dose 4Feeling: Fair · Site: Pain · Headache, Muscle or body aches, Fatigue or tiredness, NauseaAdult check-in
-
2022-09-25
Health check-in — days 1–6 daily, dose 4Feeling: Fair · Muscle or body aches, Fatigue or tiredness, NauseaAdult check-in
- 2022-09-27
- 2022-09-28
- 2022-09-29
- 2022-10-06
- 2022-10-13
- 2022-10-20
- 2022-10-27
- 2022-11-03
- 2022-12-22
-
2023-03-23
Survey response — 6 months, dose 4MedDRA: Pregnancy test positive, Small fibre neuropathy — Feeling: GoodMedDRA releases: 2024-11
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-21 | Pfizer-BioNTech | |
| 2 | 2021-04-11 | Pfizer-BioNTech | |
| 3 | 2021-08-20 | Pfizer-BioNTech | No |
| 4 | 2022-09-22 | Pfizer-BioNTech | No |
Free text
Release 10 — 6 months, dose 2
Symptoms: Received third dose of vaccine in August per PCP due to low antigen numbers in blood work. I was sick in bed for two days with body aches and headaches. Did not experience that severe reaction to first two doses.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Headache | · | · | ✓ |
| SD | Laboratory test abnormal | · | · | ✓ |
| SD | Medical counselling | · | · | ✓ |
| SD | Mobility decreased | · | · | ✓ |
| SD | Pain | · | · | ✓ |
| SD | Pregnancy test positive | · | · | ✓ |
| SD | Small fibre neuropathy | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release